KKR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Not a good buy right now for an impatient buyer: price is in a bearish downtrend (SMA_200 > SMA_20 > SMA_5) and momentum is still deteriorating (MACD histogram -2.156 and expanding negatively).", "Earnings catalyst just hit: QDEC 2025 EPS missed (0.96 vs 1.06 est.), and the stock is already weak pre-market (~103, -1.7%), increasing near-term downside/whipsaw risk.", "Oversold RSI (6) at ~15 suggests a bounce is possible, but the tape is still bearish and options positioning is defensive (high put/call ratios), so the dip is not yet \u201cconfirmed buyable.\u201d", "Intellectia Proprietary Trading Signals: AI Stock Picker = no signal today; SwingMax = no recent signal (no strong proprietary confirmation to buy this dip)."]
["Trend: Bearish. Moving averages are stacked bearishly (SMA_200 > SMA_20 > SMA_5), indicating sustained downside trend.", "Momentum: MACD histogram -2.156 (below zero) and negatively expanding -> bearish momentum is strengthening, not stabilizing yet.", "Mean-reversion setup: RSI_6 = 15.282 (deep oversold) -> probability of a short-term bounce exists, but it\u2019s counter-trend.", "Key levels: Support S1 ~103.155 (price is sitting on/near it pre-market); next support S2 ~96.632 if 103 breaks. Resistance/pivot ~113.713; meaningful recovery likely needs reclaiming/holding above this area."]
["Strategic expansion: KKR acquiring Arctos Partners for $1.4B (plus potential earnouts) strengthens positioning in sports/alternatives ecosystem.", "Fundraising strength: Record $129B new capital raised in 2025; AUM grew to $744B -> supports longer-term fee base and platform scale.", "Hedge fund activity: Hedge funds are net buyers, with buying amount up ~604.51% over the last quarter."]
["Earnings disappointment: QDEC 2025 EPS 0.96 vs 1.06 estimated; pre-market dip reflects near-term sentiment hit.", "Fee mix/transaction pressure: News notes decline in transaction fees, which can weigh on near-term earnings quality.", "Insider signal: Insiders are selling, with selling amount up ~263.26% over the last month (not supportive for an immediate buy).", "Downtrend risk: If ~103 support fails, technical room opens toward ~96.6 (S2)."]
["Latest provided quarter (2025/Q3): Revenue $7.006B (+7.52% YoY), Net Income $859.9M (+43.19% YoY), EPS $0.90 (+40.62% YoY) -> solid growth trend in Q3.", "Profitability: Gross margin 49.19% (down 10.37% YoY) -> margin compression is a watch-out.", "Latest earnings season update (QDEC 2025, reported 2026-02-05 pre-market): EPS 0.96 vs 1.06 est. (miss); operating earnings up 17% YoY per news, but the miss is driving the immediate reaction."]
["Recent trend: Mostly bullish/raising targets into 2026. Morgan Stanley raised PT to $176 (Overweight); Oppenheimer raised PT to $190 (Outperform); HSBC upgraded to Buy with $144 PT; Barclays remains Overweight (recently adjusted PTs).", "Wall Street pros: Expected ramp in deal activity/realizations, continued fundraising strength, potential multiple expansion if capital markets accelerate.", "Wall Street cons: Near-term earnings sensitivity to fees/realizations and market conditions; lingering concerns around credit performance (even if some analysts call them overblown); today\u2019s EPS miss can cap near-term upside."]
